Abstract: To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance or ameliorate the pathosis, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant or, a fraction thereof containing the compound as an active ingredient.

Abstract: 3-O-?-D-Glucopyranosyl-4-methylergost-7-en-3-ol or a composition containing 0.001% by mass or more of the aforementioned compound, which is an extract of a plant of the family Liliaceae containing the compound or a fraction thereof, is used as an active ingredient of a hyperglycemia improving agent.

Abstract: 3-O-?-D-Glucopyranosyl-4-methyl-ergost-7-en-3-ol or a composition containing 0.001 to 10% by dry mass of the aforementioned compound, which is an extract of a plant of the family Liliaceae or a fraction thereof containing the compound, is used as an active ingredient of a drug for improving pancreatic functions.

Abstract: To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity, considered to be a main factor of metabolic syndrome, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant, or a fraction thereof containing the compound is used as an active ingredient.

Abstract: The invention provides a silicone gel composition comprising: (A) an organopolysiloxane represented by an average composition formula (1) shown below: RaR1bSiO(4-a-b)/2??(1) (wherein, R represents an alkenyl group, R1 represents a monovalent hydrocarbon group that contains no aliphatic unsaturated bonds, and a, b and a+b are numbers that satisfy specific numerical ranges), and containing at least one alkenyl group bonded to a silicon atom within each molecule, (B) a component composed of: (B-1) an organohydrogenpolysiloxane represented by an average composition formula (2) shown below: (HR22SiO1/2)c(R32SiO)d(R4SiO3/2)e??(2) (wherein, R2, R3 and R4 represent monovalent hydrocarbon groups that contain no aliphatic unsaturated bonds, and c, d and e are numbers that satisfy specific numerical ranges, provided that c+d+e=1), containing at least three hydrogen atoms bonded to silicon atoms within each molecule, and containing at least two (R4SiO3/2) units within each molecule, and (B-2) an organoh

Abstract: 3-O-?-D-Glucopyranosyl-4-methylergost-7-en-3-ol or a composition containing 0.001% by mass or more of the aforementioned compound, which is an extract of a plant of the family Liliaceae containing the compound or a fraction thereof, is used as an active ingredient of a hyperglycemia improving agent.

Abstract: To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity considered to be a main factor of metabolic syndrome, there is provided an agent or a food or drink, including as an active ingredient 3-O-?-D-glucopyranosyl-4-methylergost-7-en-3-ol, an organic solvent extract, a hot water extract, a squeezed liquid of a Liliaceae plant or a fraction thereof which contains the compound.

Abstract: Compounds having a cyclolanostane skeleton such as 9,19-cyclolanostan-3-ol and 24-methylene-9,19-cyclolanostan-3-ol are used as an active ingredient of a drug and food or drink for improving pancreatic functions.

Abstract: The present invention provides: an Aloe vera extract that can be safely ingested, can be used as a material of food for preventing lifestyle diseases, contains an extremely low level of an anthraquinone (anthraquinone-based compound), and can be added to foods; and a method of producing the Aloe vera extract. A supercritical fluid extraction method can produce an Aloe vera extract containing a mixture that consists of a cyclolanostane compound and a lophenol compound in an amount of 1.0% by mass or more and having the following properties (1) and/or (2): (1) the mass mixing ratio of the cyclolanostane compound and lophenol compound is as follows: cyclolanostane compound: lophenol compound=6.3:2.7 to 5.1:4.9; and/or (2) the content of an anthraquinone-based compound is 0.001% by mass or less.

Abstract: In a one part organopolysiloxane gel composition comprising an alkenyl-containing branched organopolysiloxane, an SiH-termined organohydrogenpolysiloxane, and an addition reaction catalyst, the catalyst is obtained by heat aging a mixing of a platinum complex having an alkenyl-containing silane or organosiloxane as a ligand, a phosphite, and an organohydrogenpolysiloxane at 30-120° C. and an organic peroxide is concomitantly used. The composition inhibits addition reaction at room temperature, maintains storage stability over a long period, yet can cure rapidly at moderate temperature.

Abstract: Compounds such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol which have an activity for improving pancreatic function are used as an active ingredient of a pancreas function improving drug and food or drink.

Abstract: A silicone composition comprising (A) an organopolysiloxane having at least one lower alkenyl group in a molecule, (B) an organohydrogenpolysiloxane having at least two SiH groups in a molecule, (C) a platinum catalyst, and (D) at least one compound selected from among indoline, 1,2,3-triazole, 1,2,4-triazole, imidazole, indazole, benzoxazole, 2-hydroxybenzoxazole, 5-benzyloxyindole, 1,2-benzisoxazole, 2,1-benzisoxazole, and 1,3-benzodioxole cures effectively into a transparent rubbery or gel product having flame retardance.

Abstract: 3-O-?-D-Glucopyranosyl-4-methyl-ergost-7-en-3-ol or a composition containing 0.001 to 10% by dry mass of the aforementioned compound, which is an extract of a plant of the family Liliaceae or a fraction thereof containing the compound, is used as an active ingredient of a drug for improving pancreatic functions.

Abstract: 3-O-?-D-Glucopyranosyl-4-methylergost-7-en-3-ol or a composition containing 0.001% by mass or more of the aforementioned compound, which is an extract of a plant of the family Liliaceae containing the compound or a fraction thereof, is used as an active ingredient of a hyperglycemia improving agent.

Abstract: A curable silicone gel composition that can be applied and cured in locations where solder flux exists, the composition comprising: (A) a diorganovinylsiloxy-terminated organopolysiloxane, (B) a non-functional organopolysiloxane, (C) an organohydrogenpolysiloxane containing an average of 3 or more hydrogen atoms bonded to silicon atoms within each molecule, and (D) a hydrosilylation reaction catalyst. A method of improving the solder flux resistance of a silicone gel, and a method of forming a silicone gel with excellent solder flux resistance, both methods using the above composition.

Abstract: A compound having a cyclolanostane skeleton such as 9,19-cyclolanostan-3-ol and 24-methylene-9,19-cyclolanostan-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia.

Abstract: A compound having a hyperglycemia improving effect and a hemoglobin Alc lowering action such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia.

Abstract: A one-part polysiloxane composition comprising a branched organopolysiloxane with vinyl groups bonded to silicon atoms, an organohydrogenpolysiloxane with at least two hydrogen atoms bonded to molecular chain terminal silicon atoms within each molecule, and a platinum based catalyst, together with an additional phosphite triester and an organic peroxide, is resistant to increases in viscosity, and does not gel, even on extended storage at room temperature. Even after storage, the characteristics of the cured gel product are unchanged. Accordingly, a composition of the present invention offers excellent long term storage stability at room temperature.

Abstract: In a one part organopolysiloxane gel composition comprising an alkenyl-containing branched organopolysiloxane, an SiH-terminated organohydrogenpolysiloxane, and an addition reaction catalyst, the catalyst is obtained by heat aging a mixture of a platinum complex having an alkenyl-containing silane or organosiloxane as a ligand, a phosphite, and an organohydrogenpolysiloxane at 30-120° C. and an organic peroxide is concomitantly used. The composition inhibits addition reaction at room temperature, maintains storage stability over a long period, yet can cure rapidly at moderate temperature.

Abstract: A curable organopolysiloxane composition is provided, which includes (A) an organopolysiloxane containing at least one silicon atom-bonded alkenyl group within each molecule, (B) an organohydrogenpolysiloxane, which contains, within each molecule, at least one silicon atom-bonded hydrogen atom at a molecular chain terminal, and at least two silicon atom-bonded hydrogen atoms at non-terminal positions within the molecular chain, and which satisfies the formula shown below: 0<?/?0.25 (wherein, a represents the number of silicon atom-bonded hydrogen atoms at non-terminal positions within the molecular chain, and ? represents the total number of silicon atoms within the component (B)), in sufficient quantity to provide from 0.1 to 5 silicon atom-bonded hydrogen atoms per silicon atom-bonded alkenyl group within the component (A), and (C) a platinum-based catalyst.